Mylan Introduces Desloratadine Tablets, 5 Mg - Quick Facts

Mylan's Generic Version Of Tricor Tablets For Cholesterol Gets FDA Approval

Mylan Launches Generic Zomig Tablets

Mylan Q1 Profit Declines - Update

Mylan Q1 Profit Down 17.2%, Reaffirms FY13 Outlook - Quick Facts

Trade MYL now with

7/3/2012 7:21 AM ET

Mylan Inc. (MYL: Quote) said its subsidiary Mylan Pharmaceuticals Inc. has launched Desloratadine Tablets, 5 mg, the generic version of Schering-Plough's Clarinex allergy medication.

Earlier, Mylan obtained final approval from the U.S. Food and Drug Administration, or FDA, for its Abbreviated New Drug Application for Desloratadine Tablets, 5 mg, and is shipping this product immediately.

According to IMS Health, Desloratadine Tablets, 5 mg, had U.S. sales of around $194.6 million for the 12 months ending March 31, 2012.

Click here to receive FREE breaking news email alerts for Mylan Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 80 Articles Next>>

Editors Pick

Bank Of England Split On QE; King's Stimulus Call Defeated For Fourth Month

Bank of England Chief Mervyn King maintained his call for more stimulus for the fourth month and was defeated again by a majority of six members as in previous months who cited faster-than-expected growth and pipeline impact from previous stimulus. At his penultimate meeting, King along with Paul Fisher and David Miles sought an increase in quantitative easing by GBP 25 billion.

BoJ Keeps Easing Plan Intact; Upgrades Economic View

The Bank of Japan on Wednesday decided to keep its ultra-loose monetary policy unchanged, as expected, suggesting that the bank is moving cautiously amid concerns over the recent turmoil in the bond market. The policy board said the bank will conduct money market operations so that the monetary base will increase at an annual pace of about JPY 60-70 trillion.

Australia Consumer Morale Falls Sharply On Budget

Confidence among Australian consumers declined sharply in May to its lowest level since August 2012, driven largely by negative responses to the Federal Budget, a survey by Westpac and Melbourne Institute showed Wednesday. The index of consumer sentiment fell 7 percent in May to 97.6 from 104.9 in April. This is the lowest reading since August 2012.